The HemoCue® Glucose 201+ System puts lab-quality answers in your hands when they’re needed most – at the point of care. Not only does the unique microcuvette technology enable accurate result reading in only three simple steps, it also reduces contamination risk.
*Not available in the US, for corresponding US product, see hemocue.us
Used in screening, monitoring and as an aid in the diagnosis of diabetes mellitus, the HemoCue® Glucose 201+ System enables you to make the right decision at the point of care while reducing margins of error and risk of infection.
01
Results within 1 minute
02
Precise monitoring for better glycemic control
03
Possible to detect hypoglycemia in newborns
04
Factory calibrated analyzers means no need to recalibrate
05
Portable and battery-operated system means ideal for mobile settings
06
Microcuvette technology means reduced risk of infection spreading
Customer stories
Sorry, no results were found.
System specifications
Principle
Modified glucose degydrogenase in which the total amount of glucose is measured at the end point photometrically
Calibration
Factory calibrated and traceable to the ID GC-MS method; needs no further calibration and no coding
Power
AC Adapter or 4 AA batteries
Interface
Printer and HemoCue® Basic Connect including optional barcode scanner. Data transfer using Bluetooth® technology is possible via HemoCue® BT Connect (accessory)
The HemoCue® Glucose 201+ Systems are factory setup to provide results in either Plasma Equivalent or whole blood values. It is not possible to change this setup.
Please visit the HemoCue Web Academy to enroll in product trainings.
